GHRP-2 + CJC-1295
Not FDA approvedGrowth hormone secretagogue blend
Very thin human evidence
- Regulatory standing. Sold as a research chemical, not approved
- Limited human data. Some human data exists, not conclusive
- No registered human trials. Nothing registered on ClinicalTrials.gov
- No sources. Nothing cited to verify
Computed with the same four public criteria as every profile. The human-evidence grade on an indexed profile is set automatically and may change when it is hand-reviewed. It is not a safety score, not a purity rating, and not medical advice, and not a claim that this compound treats, cures, or prevents any condition.
What it is
This is a combination of two separate synthetic peptides: GHRP-2 (pralmorelin), a ghrelin receptor agonist, and CJC-1295, a modified growth hormone releasing hormone (GHRH) analog. Each is thought to stimulate the pituitary to release growth hormone through a different pathway, and the pairing is based on the idea that the two signals may act together.
What the evidence shows
Each component has been studied individually in small human studies showing it can raise growth hormone levels, but neither is FDA-approved, and there is no clear published human research on this specific combination as a product. Claims about the blend's benefits or safety come mainly from extrapolation and community reports.
What is in this blend
A blend is scored on its own, but the evidence for each ingredient lives on its own profile. Mixing compounds adds unknowns that none of the individual studies cover.
Sources
Risks, side effects and study doses are only published on hand-reviewed profiles. Want this one reviewed, or spotted something wrong? Tell us.